BioCentury
ARTICLE | Company News

Eisai grants 2XOncology rights to 2X-121

July 14, 2017 7:08 PM UTC

Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan 2X Oncology Inc., Cambridge, Mass.Business: CancerEisai Co. Ltd. (Tokyo:4523) granted 2X Oncology Inc. (Cambridge, Mass.) exclusive, worldwide rights to deve...